DaVita HealthCare Partners Aktie News

Analysts don't like to put "sell" ratings on S&P 500 stocks. So the fact they're willing to do it with some is worth your attention.

Banking giant BMO, Astronics, DaVita and Intercorp Financial make new highs Friday as the stock market aims to rebound.

Kidney care leader launches its next chapter of measurable impact for patients, teammates, and communities. DENVER, May 18, 2026 /PRNewswire/ -- DaVita today announced its 2030 Community Care commitments, a new set of long-term goals, focused on improving patient outcomes, supporting the expansion of economic opportunity for teammates, and strengthening community and environmental resilience.

DaVita Inc. (DVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

DaVita Inc. is upgraded to a Buy following robust Q1 results and a 23% post-earnings stock surge. DVA's Q1 non-GAAP EPS of $2.87 beat consensus, with revenue up 6% year-over-year and management raising guidance. Mid-teens EPS growth is expected through 2026, with a 10%+ FCF yield and a modest P/E ratio supporting valuation.

DENVER, May 6, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at the BofA Securities 2026 Health Care Conference on Tuesday, May 12th, 2026 at 5:20 pm Eastern Daylight Time. To view the live webcast, visit the BofA pag...

DaVita earnings jumped on rebounding dialysis treatment volumes. Here is what gives the firm a "Buffett-style" quality.

DaVita Inc. (DVA) Q1 2026 Earnings Call Transcript